Unicycive Says Suit Alleges Securities Law Violations Over Statements On Oxylanthanum Carbonate FDA Application

Unicycive is facing a lawsuit alleging violations of securities laws related to statements made about its FDA application for Oxylanthanum Carbonate. The suit claims that the company misled investors regarding the application process and its potential outcomes. The stock ticker for Unicycive is UNCY.